U.S. flag An official website of the United States government

U.S. Food and Drug Administration
  1. Home
  2. Drug Databases
  3. Orange Book Home

Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 209410

Expand all

OSMOLEX ER (AMANTADINE HYDROCHLORIDE)
EQ 129MG BASE
Marketing Status: Discontinued
Active Ingredient: AMANTADINE HYDROCHLORIDE
Proprietary Name: OSMOLEX ER
Dosage Form; Route of Administration: TABLET, EXTENDED RELEASE; ORAL
Strength: EQ 129MG BASE
Reference Listed Drug: Yes
Reference Standard: No
TE Code: 
Application Number: N209410
Product Number: 001
Approval Date: Feb 16, 2018
Applicant Holder Full Name: SUPERNUS PHARMACEUTICALS INC
Marketing Status:  Discontinued
Patent and Exclusivity Information
OSMOLEX ER (AMANTADINE HYDROCHLORIDE)
EQ 161MG BASE
Marketing Status: Discontinued
Active Ingredient: AMANTADINE HYDROCHLORIDE
Proprietary Name: OSMOLEX ER
Dosage Form; Route of Administration: TABLET, EXTENDED RELEASE; ORAL
Strength: EQ 161MG BASE
Reference Listed Drug: Yes
Reference Standard: No
TE Code: 
Application Number: N209410
Product Number: 004
Approval Date: Apr 22, 2020
Applicant Holder Full Name: SUPERNUS PHARMACEUTICALS INC
Marketing Status:  Discontinued
Patent and Exclusivity Information
OSMOLEX ER (AMANTADINE HYDROCHLORIDE)
EQ 193MG BASE
Marketing Status: Discontinued
Active Ingredient: AMANTADINE HYDROCHLORIDE
Proprietary Name: OSMOLEX ER
Dosage Form; Route of Administration: TABLET, EXTENDED RELEASE; ORAL
Strength: EQ 193MG BASE
Reference Listed Drug: Yes
Reference Standard: No
TE Code: 
Application Number: N209410
Product Number: 002
Approval Date: Feb 16, 2018
Applicant Holder Full Name: SUPERNUS PHARMACEUTICALS INC
Marketing Status:  Discontinued
Patent and Exclusivity Information
OSMOLEX ER (AMANTADINE HYDROCHLORIDE)
EQ 258MG BASE
Marketing Status: Discontinued
Active Ingredient: AMANTADINE HYDROCHLORIDE
Proprietary Name: OSMOLEX ER
Dosage Form; Route of Administration: TABLET, EXTENDED RELEASE; ORAL
Strength: EQ 258MG BASE
Reference Listed Drug: Yes
Reference Standard: No
TE Code: 
Application Number: N209410
Product Number: 003
Approval Date: Feb 16, 2018
Applicant Holder Full Name: SUPERNUS PHARMACEUTICALS INC
Marketing Status:  Discontinued
Patent and Exclusivity Information
Back to Top